|
1
|
Bulgakova NA, Klapholz B and Brown NH:
Cell adhesion in Drosophila: Versatility of cadherin and integrin
complexes during development. Curr Opin Cell Biol. 24:702–712.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leckband D and Sivasankar S: Cadherin
recognition and adhesion. Curr Opin Cell Biol. 24:620–627. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan X, Yan L, Liu S, Shan Z, Tian Y and
Jin Z: N-cadherin, a novel prognostic biomarker, drives malignant
progression of colorectal cancer. Mol Med Rep. 12:2999–3006.
2015.PubMed/NCBI
|
|
4
|
Shapiro L and Weis WI: Structure and
biochemistry of cadherins and catenins. Cold Spring Harb Perspect
Biol. 1:a0030532009. View Article : Google Scholar :
|
|
5
|
van Roy F: Beyond E-cadherin: Roles of
other cadherin superfamily members in cancer. Nat Rev Cancer.
14:121–134. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takamura M, Yamagiwa S, Matsuda Y, Ichida
T and Aoyagi Y: Involvement of liver-intestine cadherin in cancer
progression. Med Mol Morphol. 46:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartolomé RA, Barderas R, Torres S,
Fernandez-Aceñero MJ, Mendes M, García-Foncillas J, Lopez-Lucendo M
and Casal JI: Cadherin-17 interacts with α2β1 integrin to regulate
cell proliferation and adhesion in colorectal cancer cells causing
liver metastasis. Oncogene. 33:1658–1669. 2014. View Article : Google Scholar
|
|
8
|
Su MC, Yuan RH, Lin CY and Jeng YM:
Cadherin-17 is a useful diagnostic marker for adenocarcinomas of
the digestive system. Mod Pathol. 21:1379–1386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Berndorff D, Gessner R, Kreft B, Schnoy N,
Lajous-Petter AM, Loch N, Reutter W, Hortsch M and Tauber R:
Liver-intestine cadherin: Molecular cloning and characterization of
a novel Ca(2+)-dependent cell adhesion molecule expressed in liver
and intestine. J Cell Biol. 125:1353–1369. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kreft B, Berndorff D, Böttinger A,
Finnemann S, Wedlich D, Hortsch M, Tauber R and Gessner R:
LI-cadherin-mediated cell-cell adhesion does not require
cytoplasmic interactions. J Cell Biol. 136:1109–1121. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takamura M, Ichida T, Matsuda Y, Kobayashi
M, Yamagiwa S, Genda T, Shioji K, Hashimoto S, Nomoto M, Hatakeyama
K, et al: Reduced expression of liver-intestine cadherin is
associated with progression and lymph node metastasis of human
colorectal carcinoma. Cancer Lett. 212:253–259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakamoto N, Oue N, Sentani K, Anami K,
Uraoka N, Naito Y, Oo HZ, Hinoi T, Ohdan H, Yanagihara K, et al:
Liver-intestine cadherin induction by epidermal growth factor
receptor is associated with intestinal differentiation of gastric
cancer. Cancer Sci. 103:1744–1750. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu QS, Zhang J, Liu M and Dong WG:
Lentiviral-mediated miRNA against liver-intestine cadherin
suppresses tumor growth and invasiveness of human gastric cancer.
Cancer Sci. 101:1807–1812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong WG, Yu QF, Xu Y and Fan LF:
Li-cadherin is inversely correlated with galectin-3 expression in
gastric cancer. Dig Dis Sci. 53:1811–1817. 2008. View Article : Google Scholar
|
|
15
|
Park SS, Kang SH, Park JM, Kim JH, Oh SC,
Lee JH, Chae YS, Kim SJ, Kim CS and Mok YJ: Expression of
liver-intestine cadherin and its correlation with lymph node
metastasis in gastric cancer: Can it predict N stage
preoperatively? Ann Surg Oncol. 14:94–99. 2007. View Article : Google Scholar
|
|
16
|
Dong W, Yu Q and Xu Y: Altered expression
of a Li-cadherin in gastric cancer and intestinal metaplasia. Dig
Dis Sci. 52:536–542. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takamura M, Sakamoto M, Ino Y, Shimamura
T, Ichida T, Asakura H and Hirohashi S: Expression of
liver-intestine cadherin and its possible interaction with
galectin-3 in ductal adenocarcinoma of the pancreas. Cancer Sci.
94:425–430. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan ZJ, Fang XJ, Wang JX, Xue JF and Zhang
Y: Expression of liver-intestine cadherin and its significance in
hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi. 91:2546–2548.
2011.In Chinese.
|
|
19
|
Ding ZB, Shi YH, Zhou J, Shi GM, Ke AW,
Qiu SJ, Wang XY, Dai Z, Xu Y and Fan J: Liver-intestine cadherin
predicts microvascular invasion and poor prognosis of hepatitis B
virus-positive hepatocellular carcinoma. Cancer. 115:4753–4765.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen XT, Du HY, Yuan SF, Wang SM and Li M:
Effect of monoclonal antibodies against LI-cadherin on the
proliferation of human hepatocellular carcinoma cells. Nan Fang Yi
Ke Da Xue Xue Bao. 29:880–883. 2009.In Chinese. PubMed/NCBI
|
|
21
|
Wang XQ, Luk JM, Garcia-Barcelo M, Miao X,
Leung PP, Ho DW, Cheung ST, Lam BY, Cheung CK, Wong AS, et al:
Liver intestine-cadherin (CDH17) haplotype is associated with
increased risk of hepatocellular carcinoma. Clin Cancer Res.
12:5248–5252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang XQ, Luk JM, Leung PP, Wong BW,
Stanbridge EJ and Fan ST: Alternative mRNA splicing of liver
intestine-cadherin in hepatocellular carcinoma. Clin Cancer Res.
11:483–489. 2005.PubMed/NCBI
|
|
23
|
Wong BW, Luk JM, Ng IO, Hu MY, Liu KD and
Fan ST: Identification of liver-intestine cadherin in
hepatocellular carcinoma - a potential disease marker. Biochem
Biophys Res Commun. 311:618–624. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryu KH, Shim KN, Jung SA, Yoo K, Joo YH
and Lee JH: Significance of preoperative tissue levels of
vascular-endothelial cadherin, liver-intestine cadherin and
vascular endothelial growth factor in gastric cancer. Korean J
Gastroenterol. 60:229–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ko S, Chu KM, Luk JM, Wong BW, Yuen ST,
Leung SY and Wong J: Overexpression of LI-cadherin in gastric
cancer is associated with lymph node metastasis. Biochem Biophys
Res Commun. 319:562–568. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fortuna-Costa A, Gomes AM, Kozlowski EO,
Stelling MP and Pavão MS: Extracellular galectin-3 in tumor
progression and metastasis. Front Oncol. 4:1382014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Boscher C, Zheng YZ, Lakshminarayan R,
Johannes L, Dennis JW, Foster LJ and Nabi IR: Galectin-3 protein
regulates mobility of N-cadherin and GM1 ganglioside at cell-cell
junctions of mammary carcinoma cells. J Biol Chem. 287:32940–32952.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ochieng J, Fridman R, Nangia-Makker P,
Kleiner DE, Liotta LA, Stetler-Stevenson WG and Raz A: Galectin-3
is a novel substrate for human matrix metalloproteinases-2 and -9.
Biochemistry. 33:14109–14114. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu QF, Dong WG and Ren JL: Knockdown of
Li-cadherin increases metastatic behaviors of LoVo cells. J Cancer
Res Clin Oncol. 136:1641–1649. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hadler-Olsen E, Winberg JO and
Uhlin-Hansen L: Matrix metalloproteinases in cancer: Their value as
diagnostic and prognostic markers and therapeutic targets. Tumour
Biol. 34:2041–2051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brooks PC, Strömblad S, Sanders LC, von
Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP and
Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the
surface of invasive cells by interaction with integrin alpha v beta
3. Cell. 85:683–693. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rolli M, Fransvea E, Pilch J, Saven A and
Felding-Habermann B: Activated integrin alphavbeta3 cooperates with
metalloproteinase MMP-9 in regulating migration of metastatic
breast cancer cells. Proc Natl Acad Sci USA. 100:9482–9487. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ochieng J, Green B, Evans S, James O and
Warfield P: Modulation of the biological functions of galectin-3 by
matrix metalloproteinases. Biochim Biophys Acta. 1379:97–106. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song L, Tang JW, Owusu L, Sun M-Z, Wu J
and Zhang J: Galectin-3 in cancer. Clin Chim Acta. 431:185–191.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kwak JM, Min BW, Lee JH, Choi JS, Lee SI,
Park SS, Kim J, Um JW, Kim SH and Moon HY: The prognostic
significance of E-cadherin and liver intestine-cadherin expression
in colorectal cancer. Dis Colon Rectum. 50:1873–1880. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Baumgartner W: Possible roles of
LI-Cadherin in the formation and maintenance of the intestinal
epithelial barrier. Tissue Barriers. 1:e238152013. View Article : Google Scholar : PubMed/NCBI
|
